V

VolitionRX Limited

D
VNRX
USD
0.0851
(14.0964%)
Market Closed
1,397.00
Volume
-0.51
EPS
-
Div Yield
-1.722000
P/E
63,439,498.74
Market Cap
Today
14.0964%
1 Week
24.579%
1 Month
-9.380%
6 Months
-8.160%
12 Months
-17.172%
Year To Date
-1.936%
All Time
0%

Title:
VolitionRX Limited

Sector:
Healthcare
Industry:
Diagnostics & Research
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
Do you need help or have a question?